Shao, X.
Liu, H.
Hou, F.
Bai, Y.
Cui, Z.
Lin, Y.
Jiang, X.
Bai, P.
Wang, Y.
Zhang, Y.
Lu, C.
Liu, H.
Zhou, S.
Funding for this research was provided by:
Open Project of Tianjin Key Laboratory of Metabolic Diseases (ZXY-ZDSYSZD2021-1)
the National Natural Science Foundation of China (no.91746205)
Tianjin Science and Technology Plan Project Public Health Science and Technology Major Special Project (No.21ZXGWSY00100)
Article History
Received: 18 March 2022
Accepted: 1 August 2022
First Online: 16 August 2022
Declarations
:
: The authors declare that they have no competing interests.
: The study was reviewed and approved by the ethics committee of Tianjin Chu Hsien-l Memorial Hospital. The study was registered in the Chinese Clinical Trial Register with the identification number ChiCTR1900023701 (2019/06/08).
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Verbal informed consent was obtained from each participant and was recorded by the physician who explained the study procedures.
: Written informed consent for publication was obtained from all participants.